UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
OneSpan
OSPN
$618M
| $763K | ﹤0.01% |
27,330
+13,013
| +91% | +$256K |
|
1877
Arcus Biosciences
RCUS
$3.64B
| $762K | ﹤0.01% |
+30,815
| New | +$832K |
|
1878
Mativ Holdings
MATV
$711M
| $762K | ﹤0.01% |
22,813
-1,594
| -7% | -$48K |
|
1879
Encore Capital Group
ECPG
$2.13B
| $760K | ﹤0.01% |
22,226
-1,943
| -8% | -$57.9K |
|
1880
Cohu
COHU
$2.5B
| $759K | ﹤0.01% |
43,758
+2,276
| +5% | +$35.1K |
|
1881
German American Bancorp
GABC
$1.9B
| $758K | ﹤0.01% |
24,379
| – | – |
|
1882
Repay Holdings
RPAY
$327M
| $757K | ﹤0.01% |
30,720
+18,020
| +142% | +$363K |
|
1883
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $756K | ﹤0.01% |
73,549
+2,388
| +3% | +$21.7K |
|
|
TBI
1884
Trueblue
TBI
$311M
| $754K | ﹤0.01% |
49,346
+2,826
| +6% | +$42K |
|
1885
OraSure Technologies
OSUR
$279M
| $752K | ﹤0.01% |
64,701
+28,551
| +79% | +$371K |
|
1886
Acco Brands
ACCO
$407M
| $749K | ﹤0.01% |
105,514
-7,105
| -6% | -$44.2K |
|
1887
Photronics
PLAB
$1.93B
| $749K | ﹤0.01% |
67,269
+3,238
| +5% | +$37.2K |
|
1888
OFG Bancorp
OFG
$2.21B
| $748K | ﹤0.01% |
55,951
+30,296
| +118% | +$365K |
|
|
IMGN
1889
DELISTED
Immunogen Inc
IMGN
| $744K | ﹤0.01% |
161,846
+11,611
| +8% | +$49.4K |
|
1890
Enterprise Financial Services Corp
EFSC
$2.39B
| $742K | ﹤0.01% |
23,829
-1,920
| -7% | -$55.8K |
|
1891
Signet Jewelers
SIG
$3.76B
| $735K | ﹤0.01% |
71,569
+4,958
| +7% | +$49K |
|
|
SVM
1892
Silvercorp Metals
SVM
$2.53B
| $733K | ﹤0.01% |
137,531
-2,800
| -2% | -$11.8K |
|
1893
Pitney Bowes
PBI
$2.39B
| $729K | ﹤0.01% |
280,445
-7,056
| -2% | -$17.6K |
|
1894
Columbia Financial
CLBK
$1.13B
| $728K | ﹤0.01% |
52,165
-15,841
| -23% | -$221K |
|
|
NARI
1895
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $727K | ﹤0.01% |
+15,000
| New | +$716K |
|
1896
Heartland Express
HTLD
$956M
| $726K | ﹤0.01% |
34,882
-6,140
| -15% | -$123K |
|
|
SRNE
1897
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $725K | ﹤0.01% |
+115,483
| New | +$442K |
|
1898
British American Tobacco
BTI
$128B
| $725K | ﹤0.01% |
18,679
-6,560
| -26% | -$251K |
|
1899
Heritage Financial
HFWA
$1.21B
| $723K | ﹤0.01% |
36,135
+2,818
| +8% | +$53.1K |
|
1900
Sonic Automotive
SAH
$2.61B
| $721K | ﹤0.01% |
22,599
-1,418
| -6% | -$32.7K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.